Global Anti-Aging Botox Market Overview

The Global Anti-Aging Botox Market size is expected to grow from USD 20.01 billion in 2022 to USD 36.76 billion by 2030, at a CAGR of 7.9% during the forecast period (2023-2030).

Botox is a very common Anti-Aging Treatment; Anti-Aging has been done to prevent from showing aging in Facial areas. Botox (Botulinum Toxin) is a drug made from a toxin produced by (Bacterium Clostridium botulinum) Specialists used this toxin for the treatment of antiaging, they use small doses of toxins to treat wrinkles on the face, especially in the Eyes sides, Forehead, Smile area, to temporary smoothing of facial wrinkles and improving appearance. The right amount of Botox is injected by a skilled medical aesthetician into the right muscle area.

Botox is a fabulous remedy for achieving younger-looking skin. The drug is short or long-lasting depending upon the treatment chosen by the person most effective time is two months, but as said before it goes up to six months depending on the doctor and person. If it 1st treatment then the time of effect is lesser, from 2nd treatment the effect will be long-lasting. Botox increases the elasticity of muscle of the particular area by 30% in the current situation the cost of Botox can vary from $200 to $1,400 or more depending on the location, units purchased, desired profit margin, physician, etc. Botox is not only used for appearance but it will help in medical treatment also Botox has proven to be effective on people suffering from severe migraines problem.

Market Dynamics And Factors For Anti-Aging Botox Market

Drivers:

High Spending On Skincare Treatment

Spending on Skincare products and cosmetics is higher these days, which is driving the Anti-Aging Botox market during the forecast period. The use of mobiles, and social platforms, also needs to look perfect every time, competition to be active and look nice factors like these increased the spending on skincare routines and cosmetic treatment. People are becoming social media savvy, and increased awareness about anti-aging solutions helps to drive the market. Botox blocks the nerve signals from the nerves to muscles in a particular area of the body, it makes that area partially paralyzed and it appears wrinkles-free, smooth, and clean, then it seems like the person is younger than the actual age. Providing effective products & services has become on priority for market players. Spending on Skincare products and cosmetics is higher. In today’s world appearances, and looks, are much more matters, and beauty standers are particular so this market is growing tremendously.

Restraints:

High Cost of the Treatment and Post-Treatment Side Effects

The high cost of the treatment and post-treatment side effects restrain the growth of the Anti-Aging Botox market in the upcoming year. There are many therapeutic and aesthetic uses of this product but it can cause harmful post-treatment effects or various side effects are projected, it also hampers the global market size for this industry. The possible adverse effects, swelling or bruising at the injection site, include pain, droopy eyelid or cockeyed eyebrows, headache or flu-like symptoms, crooked smile or drooling, and eye dryness or excessive tearing. The high cost of these products is one of the key restraints in declining the botulinum toxin market growth.

Opportunity:

Growing Need for Skin Revitalizing Products, Especially Among the Aging Population

The growing need for skin revitalizing products, especially among the aging population is driving the growth of the Aging Botox market during the forecast period. The market has been changing constantly depending on customer demands. The influence of social media on the majority of the customer base in the market has become increased not only youth but the middle age population is also actively looking towards beauty products, serums, masks, and also Botox treatment. After particular age elasticity of the skin is become low and because of pollution, and soil, the skin shows more and more dullness, wrinkles so for a smooth effect skin revitalizing products are more consumed by the middle age group. 

Segmentation Analysis Of Anti-Aging Botox Market

By type, type A Botulinum Toxin segment is leading to dominating the anti-aging Botox market during the forecast period. Type A Botulinum Toxin segment held most of the share in 2020. The dominance of the Type A Botulinum Toxin Botox is because a large number of products are available in the market with therapeutic, cosmetic, and applications. Type A Botulinum Toxin injection is the most common, effective, cosmetic treatment carried out globally. Core aesthetic specialty organizations consistently use this formula for their treatments. Type A is approved for use in cosmetics and skincare and Type B is for clinical purposes.

By gender, the female segment is anticipated to dominate the anti-aging Botox market during the forecast period. Females are more likely to use this treatment for glowing and younger-looking skin than males, because of the responsibility, pressure, and workload the aging symptoms are seen in early-stage and the treatments are easily available everyone is available and has freedom of space to build things which are not naturally available or not so long-lasting they failed by the time passes and it leads to the growth of the anti-aging market the product which is used to suppress the natural form of skin wrinkling, in this time most of the females are using these treatments.

By application, the dermatology clinic segment is expected to lead the anti-aging Botox market over the forecast period. A dermatologist plays the main role in this Botox treatment; all the products are suggested to the patient and get verified to use for them is from a dermatologist. The order placing is also carried out by them, costing of the treatment involves four major things is the location, units purchased, and desired profit margin, physician here also plays a really important role. Most of the market share is consumed by clinical use of Botox for treatment of antiaging; they use small doses of toxins to treat wrinkles on the face, especially in the Eyes sides, Forehead, and Smile area, to temporary smoothing of facial wrinkles and improve appearance.

Regional Analysis Of Anti-Aging Botox Market

North America is the leading in the use of Anti-Aging Botox which boosts the growth of the Anti-Aging Botox Market during the forecast time. The use of antiaging treatment in countries likes the US, and Canada is very high and hence it contributes to high revenue generation globally. The regional market is dependent on the rising aged population, people are more concerned about beauty and appearance, people are more on the internet, and there is more necessity of being accepted on social platforms on different parameters of beauty, wellness, and physical appearance. Anti-Aging Botox Market is increasing constantly in North America.

The European region is expected to lead the Anti-Aging Botox market during the forecast period. The population of educated people is high in the countries of this region which are aware of the treatment carried out for the enhancement of beauty. Treatments help to remove or disappear the aging sine on the facial area. People are more aware of these treatments and are ready to spend money; these factors are driving the Anti-Aging Botox market to increase in this region.

The Asia Pacific is also expected to register the highest use of Anti-Aging Botox over the forecast period. Because it’s in the developing phase, the population is increasing, so in this region, a large pool of customers is now willing to invest more in anti-aging treatment and skincare products. The awareness about advanced skincare treatment is increased. Per capita income of people is high now so people are willing to pay for treatments like these which help to enhance their beauty, and social appearance. The Asia Pacific is anticipated to dominate the Anti-Aging Botox Market during the forecast period.

COVID 19 Impact On Anti-Aging Botox Market

COVID 19 Pandemic is a very crucial period for each and every one, world lost many lives in this period it affects all over the world in every aspect economically, and politically. In the healthcare sector because of this viral infection, many areas are working at their highest capacity like vaccines, testing kits, and masks. COVID 19 affects the manufacturing, production, and supply chain of most of the industry. Botox in hospitals and clinics is used on regular requirement but the main use of Botox is done to treat anti-aging and to improve appearance and beauty, the most frequently used area of Botox is the Eyes sides, Forehead, Smile area, for temporary smoothing of facial wrinkles. But due to covid restrictions, it is hard to do treatment for the doctor on persona face. In the time of COVID 19 situation there were some strict protocols to be followed one of them is to wear a mask but then also people wanted to do Botox, most of the part of mouth and nose is covered but people wanted to look good on the area which is not covered like forehead and eye side area. People who are fully vaccinated have permission to go outside without wearing masks so they wanted to look perfect and the market for Botox was getting the response like before the pandemic.

Top Key Players Covered In Anti-Aging Botox Market

• AllerganInc. (Ireland)
• Evolus Inc. (US)
• PfizerInc. (US)
• AbbVie (US)
• Solta Medical (US)
• Syneron Candela (US)
• Galderma S.A. (Switzerland)
• Lumenis (UK)
• Merz Pharma (Germany)
• Medy Tox Inc. (SK)
• Hugel Inc. (SK)
• Revance Therapeutics Inc. (US)
• WorldMeds LLC. (US)
• Ipsen Group (France)
• Eisai Co. Ltd. (Japan)
• Lanzhou Institute of Biological Products Co. Ltd. (China) and other major players.

Key Industry Developments In Anti-Aging Botox Market

In November 2021, NewAge announced a new anti-aging discovery and filing of patents on the new formula of that product. A patent is filled to protect the uniqueness of discovery. It includes multiple unique claims, regarding different diseases and a discovery that supports cardiovascular health and anti-aging.

In January 2020, AbbVie Inc. (Allergan) It is a leading company that is working on new product launching in the Anti-Aging Botox market for the development of the company. Allergan also opened a new R&D-based plant in Ireland to work on these anti-aging solutions. They are consistent and getting new innovative inventions in the beauty market.

In January 2020, Wockhardt launched a Botox-like anti-wrinkle gel. Wockhardt has signed its first in-licensing agreement in the anti-wrinkle.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Gender
 3.3 By Application

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Anti-Aging Botox Market by Type
 5.1 Anti-Aging Botox Market Overview Snapshot and Growth Engine
 5.2 Anti-Aging Botox Market Overview
 5.3 Type A Botulinum Toxin
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Type A Botulinum Toxin: Grographic Segmentation
 5.4 Type B Botulinum Toxin
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Type B Botulinum Toxin: Grographic Segmentation

Chapter 6: Anti-Aging Botox Market by Gender
 6.1 Anti-Aging Botox Market Overview Snapshot and Growth Engine
 6.2 Anti-Aging Botox Market Overview
 6.3 Female
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Female: Grographic Segmentation
 6.4 Male
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Male: Grographic Segmentation

Chapter 7: Anti-Aging Botox Market by Application
 7.1 Anti-Aging Botox Market Overview Snapshot and Growth Engine
 7.2 Anti-Aging Botox Market Overview
 7.3 Dermatology Clinic
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Dermatology Clinic: Grographic Segmentation
 7.4 Cosmetics
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Cosmetics: Grographic Segmentation
 7.5 Therapeutic
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Therapeutic: Grographic Segmentation
 7.6 Others
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size (2016-2028F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Others: Grographic Segmentation

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Positioning
  8.1.2 Anti-Aging Botox Sales and Market Share By Players
  8.1.3 Industry BCG Matrix
  8.1.4 Ansoff Matrix
  8.1.5 Anti-Aging Botox Industry Concentration Ratio (CR5 and HHI)
  8.1.6 Top 5 Anti-Aging Botox Players Market Share
  8.1.7 Mergers and Acquisitions
  8.1.8 Business Strategies By Top Players
 8.2 ALLERGAN INC.
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Operating Business Segments
  8.2.5 Product Portfolio
  8.2.6 Business Performance
  8.2.7 Key Strategic Moves and Recent Developments
  8.2.8 SWOT Analysis
 8.3 EVOLUS INC.
 8.4 PFIZER INC.
 8.5 ABBVIE
 8.6 SOLTA MEDICAL
 8.7 SYNERON CANDELA
 8.8 GALDERMA S.A.
 8.9 LUMENI
 8.10 MERZ PHARMA
 8.11 MEDY TOX INC.
 8.12 HUGEL INC.
 8.13 REVANCE THERAPEUTICS INC.
 8.14 WORLDMEDS LLC.
 8.15 IPSEN GROUP
 8.16 EISAI CO. LTD.
 8.17 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO. LTD
 8.18 OTHER MAJOR PLAYERS

Chapter 9: Global Anti-Aging Botox Market Analysis, Insights and Forecast, 2016-2028
 9.1 Market Overview
 9.2 Historic and Forecasted Market Size By Type
  9.2.1 Type A Botulinum Toxin
  9.2.2 Type B Botulinum Toxin
 9.3 Historic and Forecasted Market Size By Gender
  9.3.1 Female
  9.3.2 Male
 9.4 Historic and Forecasted Market Size By Application
  9.4.1 Dermatology Clinic
  9.4.2 Cosmetics
  9.4.3 Therapeutic
  9.4.4 Others

Chapter 10: North America Anti-Aging Botox Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Type A Botulinum Toxin
  10.4.2 Type B Botulinum Toxin
 10.5 Historic and Forecasted Market Size By Gender
  10.5.1 Female
  10.5.2 Male
 10.6 Historic and Forecasted Market Size By Application
  10.6.1 Dermatology Clinic
  10.6.2 Cosmetics
  10.6.3 Therapeutic
  10.6.4 Others
 10.7 Historic and Forecast Market Size by Country
  10.7.1 U.S.
  10.7.2 Canada
  10.7.3 Mexico

Chapter 11: Europe Anti-Aging Botox Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Type A Botulinum Toxin
  11.4.2 Type B Botulinum Toxin
 11.5 Historic and Forecasted Market Size By Gender
  11.5.1 Female
  11.5.2 Male
 11.6 Historic and Forecasted Market Size By Application
  11.6.1 Dermatology Clinic
  11.6.2 Cosmetics
  11.6.3 Therapeutic
  11.6.4 Others
 11.7 Historic and Forecast Market Size by Country
  11.7.1 Germany
  11.7.2 U.K.
  11.7.3 France
  11.7.4 Italy
  11.7.5 Russia
  11.7.6 Spain
  11.7.7 Rest of Europe

Chapter 12: Asia-Pacific Anti-Aging Botox Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Type A Botulinum Toxin
  12.4.2 Type B Botulinum Toxin
 12.5 Historic and Forecasted Market Size By Gender
  12.5.1 Female
  12.5.2 Male
 12.6 Historic and Forecasted Market Size By Application
  12.6.1 Dermatology Clinic
  12.6.2 Cosmetics
  12.6.3 Therapeutic
  12.6.4 Others
 12.7 Historic and Forecast Market Size by Country
  12.7.1 China
  12.7.2 India
  12.7.3 Japan
  12.7.4 Singapore
  12.7.5 Australia
  12.7.6 New Zealand
  12.7.7 Rest of APAC

Chapter 13: Middle East & Africa Anti-Aging Botox Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Type A Botulinum Toxin
  13.4.2 Type B Botulinum Toxin
 13.5 Historic and Forecasted Market Size By Gender
  13.5.1 Female
  13.5.2 Male
 13.6 Historic and Forecasted Market Size By Application
  13.6.1 Dermatology Clinic
  13.6.2 Cosmetics
  13.6.3 Therapeutic
  13.6.4 Others
 13.7 Historic and Forecast Market Size by Country
  13.7.1 Turkey
  13.7.2 Saudi Arabia
  13.7.3 Iran
  13.7.4 UAE
  13.7.5 Africa
  13.7.6 Rest of MEA

Chapter 14: South America Anti-Aging Botox Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 Type A Botulinum Toxin
  14.4.2 Type B Botulinum Toxin
 14.5 Historic and Forecasted Market Size By Gender
  14.5.1 Female
  14.5.2 Male
 14.6 Historic and Forecasted Market Size By Application
  14.6.1 Dermatology Clinic
  14.6.2 Cosmetics
  14.6.3 Therapeutic
  14.6.4 Others
 14.7 Historic and Forecast Market Size by Country
  14.7.1 Brazil
  14.7.2 Argentina
  14.7.3 Rest of SA

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. ANTI-AGING BOTOX MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. ANTI-AGING BOTOX MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. ANTI-AGING BOTOX MARKET COMPETITIVE RIVALRY
TABLE 005. ANTI-AGING BOTOX MARKET THREAT OF NEW ENTRANTS
TABLE 006. ANTI-AGING BOTOX MARKET THREAT OF SUBSTITUTES
TABLE 007. ANTI-AGING BOTOX MARKET BY TYPE
TABLE 008. TYPE A BOTULINUM TOXIN MARKET OVERVIEW (2016-2028)
TABLE 009. TYPE B BOTULINUM TOXIN MARKET OVERVIEW (2016-2028)
TABLE 010. ANTI-AGING BOTOX MARKET BY GENDER
TABLE 011. FEMALE MARKET OVERVIEW (2016-2028)
TABLE 012. MALE MARKET OVERVIEW (2016-2028)
TABLE 013. ANTI-AGING BOTOX MARKET BY APPLICATION
TABLE 014. DERMATOLOGY CLINIC MARKET OVERVIEW (2016-2028)
TABLE 015. COSMETICS MARKET OVERVIEW (2016-2028)
TABLE 016. THERAPEUTIC MARKET OVERVIEW (2016-2028)
TABLE 017. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 018. NORTH AMERICA ANTI-AGING BOTOX MARKET, BY TYPE (2016-2028)
TABLE 019. NORTH AMERICA ANTI-AGING BOTOX MARKET, BY GENDER (2016-2028)
TABLE 020. NORTH AMERICA ANTI-AGING BOTOX MARKET, BY APPLICATION (2016-2028)
TABLE 021. N ANTI-AGING BOTOX MARKET, BY COUNTRY (2016-2028)
TABLE 022. EUROPE ANTI-AGING BOTOX MARKET, BY TYPE (2016-2028)
TABLE 023. EUROPE ANTI-AGING BOTOX MARKET, BY GENDER (2016-2028)
TABLE 024. EUROPE ANTI-AGING BOTOX MARKET, BY APPLICATION (2016-2028)
TABLE 025. ANTI-AGING BOTOX MARKET, BY COUNTRY (2016-2028)
TABLE 026. ASIA PACIFIC ANTI-AGING BOTOX MARKET, BY TYPE (2016-2028)
TABLE 027. ASIA PACIFIC ANTI-AGING BOTOX MARKET, BY GENDER (2016-2028)
TABLE 028. ASIA PACIFIC ANTI-AGING BOTOX MARKET, BY APPLICATION (2016-2028)
TABLE 029. ANTI-AGING BOTOX MARKET, BY COUNTRY (2016-2028)
TABLE 030. MIDDLE EAST & AFRICA ANTI-AGING BOTOX MARKET, BY TYPE (2016-2028)
TABLE 031. MIDDLE EAST & AFRICA ANTI-AGING BOTOX MARKET, BY GENDER (2016-2028)
TABLE 032. MIDDLE EAST & AFRICA ANTI-AGING BOTOX MARKET, BY APPLICATION (2016-2028)
TABLE 033. ANTI-AGING BOTOX MARKET, BY COUNTRY (2016-2028)
TABLE 034. SOUTH AMERICA ANTI-AGING BOTOX MARKET, BY TYPE (2016-2028)
TABLE 035. SOUTH AMERICA ANTI-AGING BOTOX MARKET, BY GENDER (2016-2028)
TABLE 036. SOUTH AMERICA ANTI-AGING BOTOX MARKET, BY APPLICATION (2016-2028)
TABLE 037. ANTI-AGING BOTOX MARKET, BY COUNTRY (2016-2028)
TABLE 038. ALLERGAN INC.: SNAPSHOT
TABLE 039. ALLERGAN INC.: BUSINESS PERFORMANCE
TABLE 040. ALLERGAN INC.: PRODUCT PORTFOLIO
TABLE 041. ALLERGAN INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. EVOLUS INC.: SNAPSHOT
TABLE 042. EVOLUS INC.: BUSINESS PERFORMANCE
TABLE 043. EVOLUS INC.: PRODUCT PORTFOLIO
TABLE 044. EVOLUS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. PFIZER INC.: SNAPSHOT
TABLE 045. PFIZER INC.: BUSINESS PERFORMANCE
TABLE 046. PFIZER INC.: PRODUCT PORTFOLIO
TABLE 047. PFIZER INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. ABBVIE: SNAPSHOT
TABLE 048. ABBVIE: BUSINESS PERFORMANCE
TABLE 049. ABBVIE: PRODUCT PORTFOLIO
TABLE 050. ABBVIE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. SOLTA MEDICAL: SNAPSHOT
TABLE 051. SOLTA MEDICAL: BUSINESS PERFORMANCE
TABLE 052. SOLTA MEDICAL: PRODUCT PORTFOLIO
TABLE 053. SOLTA MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. SYNERON CANDELA: SNAPSHOT
TABLE 054. SYNERON CANDELA: BUSINESS PERFORMANCE
TABLE 055. SYNERON CANDELA: PRODUCT PORTFOLIO
TABLE 056. SYNERON CANDELA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. GALDERMA S.A.: SNAPSHOT
TABLE 057. GALDERMA S.A.: BUSINESS PERFORMANCE
TABLE 058. GALDERMA S.A.: PRODUCT PORTFOLIO
TABLE 059. GALDERMA S.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. LUMENI: SNAPSHOT
TABLE 060. LUMENI: BUSINESS PERFORMANCE
TABLE 061. LUMENI: PRODUCT PORTFOLIO
TABLE 062. LUMENI: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. MERZ PHARMA: SNAPSHOT
TABLE 063. MERZ PHARMA: BUSINESS PERFORMANCE
TABLE 064. MERZ PHARMA: PRODUCT PORTFOLIO
TABLE 065. MERZ PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. MEDY TOX INC.: SNAPSHOT
TABLE 066. MEDY TOX INC.: BUSINESS PERFORMANCE
TABLE 067. MEDY TOX INC.: PRODUCT PORTFOLIO
TABLE 068. MEDY TOX INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 068. HUGEL INC.: SNAPSHOT
TABLE 069. HUGEL INC.: BUSINESS PERFORMANCE
TABLE 070. HUGEL INC.: PRODUCT PORTFOLIO
TABLE 071. HUGEL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 071. REVANCE THERAPEUTICS INC.: SNAPSHOT
TABLE 072. REVANCE THERAPEUTICS INC.: BUSINESS PERFORMANCE
TABLE 073. REVANCE THERAPEUTICS INC.: PRODUCT PORTFOLIO
TABLE 074. REVANCE THERAPEUTICS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 074. WORLDMEDS LLC.: SNAPSHOT
TABLE 075. WORLDMEDS LLC.: BUSINESS PERFORMANCE
TABLE 076. WORLDMEDS LLC.: PRODUCT PORTFOLIO
TABLE 077. WORLDMEDS LLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 077. IPSEN GROUP: SNAPSHOT
TABLE 078. IPSEN GROUP: BUSINESS PERFORMANCE
TABLE 079. IPSEN GROUP: PRODUCT PORTFOLIO
TABLE 080. IPSEN GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 080. EISAI CO. LTD.: SNAPSHOT
TABLE 081. EISAI CO. LTD.: BUSINESS PERFORMANCE
TABLE 082. EISAI CO. LTD.: PRODUCT PORTFOLIO
TABLE 083. EISAI CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 083. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO. LTD: SNAPSHOT
TABLE 084. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO. LTD: BUSINESS PERFORMANCE
TABLE 085. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO. LTD: PRODUCT PORTFOLIO
TABLE 086. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 086. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 087. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 088. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 089. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. ANTI-AGING BOTOX MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. ANTI-AGING BOTOX MARKET OVERVIEW BY TYPE
FIGURE 012. TYPE A BOTULINUM TOXIN MARKET OVERVIEW (2016-2028)
FIGURE 013. TYPE B BOTULINUM TOXIN MARKET OVERVIEW (2016-2028)
FIGURE 014. ANTI-AGING BOTOX MARKET OVERVIEW BY GENDER
FIGURE 015. FEMALE MARKET OVERVIEW (2016-2028)
FIGURE 016. MALE MARKET OVERVIEW (2016-2028)
FIGURE 017. ANTI-AGING BOTOX MARKET OVERVIEW BY APPLICATION
FIGURE 018. DERMATOLOGY CLINIC MARKET OVERVIEW (2016-2028)
FIGURE 019. COSMETICS MARKET OVERVIEW (2016-2028)
FIGURE 020. THERAPEUTIC MARKET OVERVIEW (2016-2028)
FIGURE 021. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 022. NORTH AMERICA ANTI-AGING BOTOX MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. EUROPE ANTI-AGING BOTOX MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. ASIA PACIFIC ANTI-AGING BOTOX MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. MIDDLE EAST & AFRICA ANTI-AGING BOTOX MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 026. SOUTH AMERICA ANTI-AGING BOTOX MARKET OVERVIEW BY COUNTRY (2016-2028)